47045-BFA-C-FDC-1 The Global Fund to Fight AIDS, Tuberculosis and Malaria Burkina Faso, TB/HIV, Faso - Action pour le Développement Communautaire Goals: Améliorer l’état de santé de la population // Improve the health status of the population; Contribuer à l'amélioration de l'état de santé de la population en réduisant le fardeau du paludisme d'ici 2026 // Contribute to improving the health status of the population by reducing the burden of malaria by 2026; Contribuer à l’amélioration de l’état de santé de la population du Burkina Faso en réduisant le poids de la tuberculose d’ici à fin 2026. // Contribute to improving the health status of the population of Burkina Faso by reducing the burden of tuberculosis by the end of 2026; Contribuer à l’amélioration de l’état de santé de la population du Burkina Faso en réduisant le poids du VIH d’ici à fin 2026. // Contribute to improving the health status of the population of Burkina Faso by reducing the burden of HIV by the end of 2026. Objectives: Augmenter l’utilisation des services de santé pour réduire les mortalités et morbidités dues aux maladies transmissibles et non transmissibles // Increase the use of health services to reduce mortality and morbidity due to communicable and non-communicable diseases; Rendre disponible les infrastructures sanitaires, les équipements et les produits de santé, selon les normes et les besoins, dans 95% des formations sanitaires. // Make health infrastructures, equipment and products available, according to standards and needs, in 95% of health facilities; Renforcer la lutte contre les maladies et la promotion de la santé à travers les attitudes et les pratiques individuelles, familiales et communautaires. // Strengthen disease control and health promotion through individual, family and community attitudes and practices; Assurer la disponibilité et l’utilisation d’informations sanitaires de qualité pour la prise de décisions à tous les niveaux. // Ensure the availability and use of quality health information for decision-making at all levels; Réduire le taux de mortalité du paludisme d’au moins 75% par rapport à 2015 au Burkina Faso d’ici à fin 2026. // Reduce the malaria mortality rate in Burkina Faso by at least 75% compared with 2015, by the end of 2026; Réduire l’incidence du paludisme d’au moins 75% par rapport à 2015 au Burkina Faso d’ici à fin 2026. // Reduce the incidence of malaria in Burkina Faso by at least 75% compared with 2015, by the end of 2026; Réduire l’incidence de la tuberculose de 45 en 2021 à 36 cas/100 000 habitants en 2026. // Reduce the incidence of tuberculosis from 45 in 2021 to 36 cases/100,000 inhabitants in 2026; Reduire le taux de mortalité de la tuberculose de 6,4 en 2021 à 1,5 décès/100 000 habitants d’ici à fin 2026. // Reduce the tuberculosis mortality rate from 6.4 in 2021 to 1.5 deaths/100,000 inhabitants by the end of 2026; Accroître le taux de succès au traitement des patients TB pharmaco sensibles de 81,5% (cohorte 2020) à au moins 90% (cohorte 2025) et ceux TB-résistante de 75% (cohorte 2020) à au moins 80% (cohorte 2025). // Increase the treatment success rate for drug-susceptible TB patients from 81.5% (cohort 2020) to at least 90% (cohort 2025), and for drug-resistant TB patients from 75% (cohort 2020) to at least 80% (cohort 2025); Les nouvelles infections à VIH sont réduites de 75% à l’horizon 2026. // New HIV infections reduced by 75% by 2026; La mortalité liée au VIH est réduite de 70% chez les PVVIH y compris chez les co-infectées à l'horizon 2025 // HIV-related mortality reduced by 70% among PLHIV, including co-infected people, by 2025; 95% des personnes infectées et affectées par le VIH ainsi que les OEV du SIDA ont une qualité de vie améliorée en matière de droits, d’égalité du genre de soutien et de protection à l'horizon 2026. // 95% of people infected and affected by HIV and OVC living with AIDS have an improved quality of life in terms of rights, gender equality, support and protection by 2026. The Global Fund to Fight AIDS, Tuberculosis and Malaria Faso - Action pour le Développement Communautaire Faso - Action pour le Développement Communautaire The Global Fund to Fight AIDS, Tuberculosis and Malaria The Global Fund to Fight AIDS, Tuberculosis and Malaria Communications +41 58 791 1700 website@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland The Global Fund to Fight AIDS, Tuberculosis and Malaria Grant Management Division Lilian Pedrosa Fund Portfolio Manager +41 58 791 1700 lilian.pedrosa@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland Burkina Faso HIV Multicomponent, RSSH Tuberculosis Ensure healthy lives and promote well-being for all at all ages End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases Achieve universal health coverage HIV -> Differentiated HIV Testing Services -> Community-based testing for KP programs HIV -> Prevention package for men who have sex with men (MSM) and their sexual partners -> HIV prevention communication, information and demand creation for MSM HIV -> Prevention package for men who have sex with men (MSM) and their sexual partners -> Pre-exposure prophylaxis (PrEP) programming for MSM HIV -> Prevention package for people in prisons and other closed settings -> HIV prevention communication, information and demand creation for prisoners HIV -> Prevention package for sex workers, their clients and other sexual partners -> HIV prevention communication, information and demand creation for sex workers HIV -> Reducing human rights-related barriers to HIV/TB services -> Community mobilization and advocacy for human rights HIV -> Reducing human rights-related barriers to HIV/TB services -> Eliminating stigma and discrimination in all settings HIV -> Reducing human rights-related barriers to HIV/TB services -> Ensuring nondiscriminatory provision of health care HIV -> Reducing human rights-related barriers to HIV/TB services -> Ensuring rights-based law enforcement practices HIV -> Reducing human rights-related barriers to HIV/TB services -> Increasing access to justice (HIV/TB) HIV -> Reducing human rights-related barriers to HIV/TB services -> Legal literacy ("Know Your Rights") (HIV/TB) HIV -> Reducing human rights-related barriers to HIV/TB services -> Reducing HIV-related gender discrimination, harmful gender norms and violence against women and girls in all their diversity HIV -> Treatment, care and support -> HIV treatment and differentiated service delivery - adults (15 and above) HIV -> Treatment, care and support -> HIV treatment and differentiated service delivery - children (under 15) Multicomponent -> Program management -> Grant management RSSH -> RSSH: Community systems strengthening -> Capacity building and leadership development RSSH -> RSSH: Monitoring and evaluation systems -> Data quality RSSH -> RSSH: Monitoring and evaluation systems -> Routine reporting Tuberculosis -> Collaboration with other providers and sectors -> Community-based TB/DR-TB care Tuberculosis -> Drug-resistant (DR)-TB diagnosis, treatment and care -> DR-TB diagnosis/drug susceptibility testing (DST) Tuberculosis -> Drug-resistant (DR)-TB diagnosis, treatment and care -> DR-TB treatment, care and support Tuberculosis -> Key and vulnerable populations (KVP) - TB/DR-TB -> KVP - Miners and mining communities Tuberculosis -> Key and vulnerable populations (KVP) - TB/DR-TB -> KVP - Mobile population (migrants/refugees/IDPs) Tuberculosis -> Removing human rights and gender related barriers to TB services -> Eliminating TB-related stigma and discrimination Tuberculosis -> TB/HIV -> TB/HIV - Screening, testing and diagnosis Tuberculosis -> TB/HIV -> TB/HIV - Treatment and care 3492960.02 3371264.57 3289939.97 Global Fund commitment to BFA-C-FDCP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Faso - Action pour le Développement Communautaire 1310014.73 Global Fund disbursement to BFA-C-FDCP01 (Other Local Organizations). The Global Fund to Fight AIDS, Tuberculosis and Malaria Faso - Action pour le Développement Communautaire 7369.60 Global Fund disbursement to BFA-C-FDCP01 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria Faso - Action pour le Développement Communautaire 6634.37 Global Fund disbursement to BFA-C-FDCP01 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria Faso - Action pour le Développement Communautaire 1743994.17 Global Fund disbursement to BFA-C-FDCP01 (Other Local Organizations). The Global Fund to Fight AIDS, Tuberculosis and Malaria Faso - Action pour le Développement Communautaire 7436.19 Global Fund disbursement to BFA-C-FDCP01 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria Faso - Action pour le Développement Communautaire 7334.92 Global Fund disbursement to BFA-C-FDCP01 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria Faso - Action pour le Développement Communautaire 3393809.52 Global Fund commitment to BFA-C-FDCP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Faso - Action pour le Développement Communautaire -207155.99 Global Fund commitment to BFA-C-FDCP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria Faso - Action pour le Développement Communautaire 1053958.27 Global Fund disbursement to BFA-C-FDCP01 (Other Local Organizations). The Global Fund to Fight AIDS, Tuberculosis and Malaria Faso - Action pour le Développement Communautaire 7907.62 Global Fund disbursement to BFA-C-FDCP01 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria Faso - Action pour le Développement Communautaire 14657.68 Global Fund disbursement to BFA-C-FDCP01 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria Faso - Action pour le Développement Communautaire 2296114.74 Global Fund disbursement to BFA-C-FDCP01 (Other Local Organizations). The Global Fund to Fight AIDS, Tuberculosis and Malaria Faso - Action pour le Développement Communautaire 7057.07 Global Fund disbursement to BFA-C-FDCP01 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria Faso - Action pour le Développement Communautaire 689199.60 Expenditure reported by Faso - Action pour le Développement Communautaire for BFA-C-FDCP01, Jan 2025 to Dec 2025. Faso - Action pour le Développement Communautaire An overview of a grant over its lifetime. General terms and conditions which apply to Global Fund grants. Funding Request of funding request FR1537-BFA-Z. Funding Request of funding request FR1537-BFA-Z. 1 - (1) In accordance with the Global Fund’s Sustainability, Transition and Co-financing Policy (GF/B35/04) (the “STC Policy”), the commitment and disbursement of EUR 7,556,428 (the “Co-Financing Incentive”), is subject to the Global Fund’s satisfaction with the Host Country’s compliance with the requirements listed at 5.1(1)(a) and 5.1(1)(b) below (“Co-Financing Requirements”). The Grantee acknowledges and agrees that the Global Fund may reduce Grant Funds during the current or any subsequent Implementation Period in the event the Host Country fails to: (a) maintain government expenditure on health to meet national universal health coverage goals; and/or (b) maintain domestic funding of Global Fund-supported programs, with a focus on progressively absorbing the key costs of national disease plans, as identified in consultation with the Global Fund. (2) In order to satisfy the Co-Financing Requirements, the Grantee acknowledges and agrees that the Host Country shall, as set out in as set out in the Commitment Letter dated 19 March 2023 (the “Commitment Letter”), unless otherwise agreed in writing by the Global Fund: (a) fulfil a total minimum co-financing commitment of EUR 191,144,678 from 2024-2026 (inclusive), comprising investments in: i. HIV of EUR 41,472,782; and ii. tuberculosis of EUR 2,127,333; (b) fulfil the programmatic commitments as stipulated in Section 1.3 of the Commitment Letter; and (c) provide to the Global Fund, by no later than 30 June and 15 August of each year of the Implementation Period and the year following the end of the Implementation Period, evidence supporting achievement of the Co-Financing Requirements, including: i. the approved annual budget for the specific HIV/AIDS and tuberculosis Budget lines for the upcoming year; and ii. the total expenditure for the specific HIV/AIDS and tuberculosis Budget lines in the previous fiscal year. 2 - The procurement of Health Products shall be carried out through the Pooled Procurement Mechanism (“PPM”) of the Global Fund, unless the Global Fund directs the Principal Recipient otherwise in writing. The Principal Recipient has all the necessary power and authority to execute, deliver and carry out its obligations under the wambo.org – PPM registration letter in the form approved by the Global Fund. 3 - (1) Grant Funds may be used to pay for the services of an external auditor or for a Supreme Audit Institution approved by the Global Fund retained by the Global Fund for the annual independent audit of the Program (the “External Auditor”) and the Global Fund may disburse such Grant Funds directly to the External Auditor; (2) the Principal Recipient shall consent, no later than 30 March 2025, to the carrying out of audits of the Program by the External Auditor for the period covering fiscal years 2025 and 2026 (and other such additional periods as the Global Fund may communicate to the Principal Recipient in writing0), and to the terms of reference of the External Auditor and agrees that such terms of reference may be amended from time to time; and (3) without limiting Section 7.5 of the Global Fund Grant Regulations (as amended from time to time), the Principal Recipient shall cooperate fully with the External Auditor to allow the External Auditor to perform its services, including by providing all information and documents requested by the External Auditor or the Global Fund. 4 - (1) Grant Funds may be used to pay for services performed by a fiscal agent retained by the Global Fund (the “Fiscal Agent”) and the Global Fund may disburse such Grant Funds directly to the Fiscal Agent; (2) The Principal Recipient consents to the terms of reference of the Fiscal Agent and agrees that such terms of reference may be amended from time to time at the Global Fund’s discretion; (3) The Principal Recipient shall take all necessary actions under applicable laws, regulations, rules and procedures to grant to the Fiscal Agent co-signature authority to all bank accounts of the Principal Recipient in which Grant Funds are held (“Program Accounts”) and give full effect thereto, and shall provide evidence thereof to the Global Fund upon request. The Principal Recipient shall not change any Program Account without the Global Fund’s prior written approval, which shall be subject, among others, to receipt by the Global Fund of evidence of co-signature authority pursuant to the immediately preceding sentence; (4) The Principal Recipient shall cooperate fully with the Fiscal Agent to allow the Fiscal Agent to perform its services, including, but not limited to, by (a) providing all information requested by the Fiscal Agent or the Global Fund; (b) taking all necessary actions prior to collection of Personal Data and at all times thereafter to ensure that the processing of Personal Data by the Fiscal Agent does not violate any applicable law or regulation; and (c) implementing any recommendations made by the Fiscal Agent; and (5) The appointment of the Fiscal Agent shall not, nor shall it be construed to, discharge the Grantee of their respective obligations under the Grant Agreement, which shall remain in full force and effect. The Fiscal Agent shall not have authority to act as the Global Fund’s agent, unless provided otherwise in writing by the Global Fund. Accordingly, the Global Fund reserves the right to classify any expenditure of Grant Funds as non-compliant, notwithstanding its verification or endorsement by the Fiscal Agent. 5 - The Global Fund may disburse Grant Funds in a currency other than that specified in the Grant Confirmation, including the United States Dollar. In such cases, the exchange rate used to calculate the amount of the disbursement into its equivalent in the currency specified in the Grant Confirmation shall be the relevant exchange rate reflected in the Program budget. 6 - Prior to the use of Grant Funds by the Principal Recipient to finance human resources costs, including Program staff salaries (budget lines 13 and 20 of the Program budget), the Principal Recipient shall submit to the Global Fund, and obtain the Global Fund's written approval of, the terms of reference and the respective benefits for each Program staff position. 8 - Prior to the use of EUR 23,530 in Grant Funds to finance capacity building activities (budget line 11 of the Program budget), the Principal Recipient shall submit to the Global Fund, and obtain the Global Fund’s written approval of, relevant terms of reference and a detailed budget. 9 - Prior to the procurement of Fixed Assets for the Program, the Principal Recipient shall submit to the Global Fund, and obtain the Global Fund’s written approval of, a detailed list of Fixed Assets, including those transferred from BFA-C-IPC to the Principal Revcipient for use under the Grant. Module: Differentiated HIV Testing Services. Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - other. Numerator: 4546; Denominator: 17381. Numerator: 9062.7; Denominator: 18354. Numerator: 2587; Denominator: 18354. Numerator: 9062.73; Denominator: 18354. Numerator: 9062.73; Denominator: 18354. Numerator: 2587; Denominator: 18354. Numerator: 10221.84; Denominator: 18860. Numerator: 10221.84; Denominator: 18860. Module: Differentiated HIV Testing Services. Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - other. Numerator: 30674; Denominator: 52003; Percentage: 58.99%. Numerator: 15037; Denominator: 52003; Percentage: 28.92%. Numerator: 30674; Denominator: 52003; Percentage: 58.99%. Numerator: 31626.9; Denominator: 54913; Percentage: 57.6%. Numerator: 14323; Denominator: 54913; Percentage: 26.08%. Numerator: 31626.9; Denominator: 54913; Percentage: 57.59%. Numerator: 31626.9; Denominator: 54913; Percentage: 57.59%. Numerator: 14323; Denominator: 54913; Percentage: 26.08%. Numerator: 7375. Numerator: 14323. Numerator: 31646.7; Denominator: 56429; Percentage: 56.08%. Numerator: 31646.7; Denominator: 56429; Percentage: 56.08%. Module: Prevention package for men who have sex with men (MSM) and their sexual partners. Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - other. Numerator: 4858; Denominator: 17381. Numerator: 10069.7; Denominator: 18354. Numerator: 7599; Denominator: 18354. Numerator: 10069.7; Denominator: 18354. Numerator: 10069.7; Denominator: 18354. Numerator: 7599; Denominator: 18354. Numerator: 11357.6; Denominator: 18860. Numerator: 11357.6; Denominator: 18860. Module: Prevention package for men who have sex with men (MSM) and their sexual partners. Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. Numerator: 294; Denominator: 2129; Percentage: 13.81%. Numerator: 98. Numerator: 196. Numerator: 665. Numerator: 98. Numerator: 626. Numerator: 114.5. Numerator: 114.5. Module: Prevention package for sex workers, their clients and other sexual partners. Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. Numerator: 1067; Denominator: 3199; Percentage: 33.35%. Numerator: 1067; Denominator: 3199; Percentage: 33.35%. Numerator: 1067; Denominator: 3199; Percentage: 33.35%. Numerator: 348. Numerator: 2421. Numerator: 174. Numerator: 174. Numerator: 2365. Numerator: 2365. Numerator: 2365. Numerator: 174.5. Numerator: 174.5. Module: Prevention package for sex workers, their clients and other sexual partners. Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - other. Numerator: 29632; Denominator: 52003; Percentage: 56.98%. Numerator: 14655; Denominator: 52003; Percentage: 28.18%. Numerator: 29632; Denominator: 52003; Percentage: 56.98%. Numerator: 35141; Denominator: 54913; Percentage: 64%. Numerator: 46126; Denominator: 54913; Percentage: 84%. Numerator: 35141; Denominator: 54913; Percentage: 63.99%. Numerator: 35141; Denominator: 54913; Percentage: 63.99%. Numerator: 46126; Denominator: 54913; Percentage: 84%. Numerator: 21225. Numerator: 46126. Numerator: 35163; Denominator: 56429; Percentage: 62.31%. Numerator: 35163; Denominator: 56429; Percentage: 62.31%. Module: RSSH: Monitoring and evaluation systems. Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. Numerator: 1776; Denominator: 1776. Numerator: 306; Denominator: 306. Numerator: 612; Denominator: 612. Numerator: 460; Denominator: 519. Numerator: 306; Denominator: 306. Numerator: 342; Denominator: 165. Numerator: 306; Denominator: 306. Numerator: 306; Denominator: 306. Module: TB diagnosis, treatment and care. Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. Numerator: 2305; Denominator: 7320. Numerator: 3362; Denominator: 8405. Numerator: 1174; Denominator: 10308. Numerator: 1681; Denominator: 4202.5. Numerator: 1681; Denominator: 4202.5. Numerator: 821; Denominator: 5194. Numerator: 1752.6; Denominator: 4381.5. Numerator: 1752.6; Denominator: 4381.5.